INSERM, U 1229, Laboratoire Regenerative Medicine and Skeleton (RMeS), 1 place Alexis Ricordeau, Nantes F - 44042, France.
Service de Chirurgie Maxillo faciale, Plastique et Brulés, Hôpital Trousseau, CHU de Tours, Avenue de la République, Chambray-lès-Tours F - 37170, France.
ACS Biomater Sci Eng. 2020 Jan 13;6(1):553-563. doi: 10.1021/acsbiomaterials.9b01241. Epub 2019 Nov 22.
Finding alternative strategies for the regeneration of craniofacial bone defects (CSD), such as combining a synthetic ephemeral calcium phosphate (CaP) implant and/or active substances and cells, would contribute to solving this reconstructive roadblock. However, CaP's architectural features (i.e., architecture and composition) still need to be tailored, and the use of processed stem cells and synthetic active substances (e.g., recombinant human bone morphogenetic protein 2) drastically limits the clinical application of such approaches. Focusing on solutions that are directly transposable to the clinical setting, biphasic calcium phosphate (BCP) and carbonated hydroxyapatite (CHA) 3D-printed disks with a triply periodic minimal structure (TPMS) were implanted in calvarial critical-sized defects (rat model) with or without addition of total bone marrow (TBM). Bone regeneration within the defect was evaluated, and the outcomes were compared to a standard-care procedure based on BCP granules soaked with TBM (positive control). After 7 weeks, de novo bone formation was significantly greater in the CHA disks + TBM group than in the positive controls (3.33 mm and 2.15 mm, respectively, P=0.04). These encouraging results indicate that both CHA and TPMS architectures are potentially advantageous in the repair of CSDs and that this one-step procedure warrants further clinical investigation.
寻找用于颅颌面骨缺损 (CSD) 再生的替代策略,例如结合合成的短暂性磷酸钙 (CaP) 植入物和/或活性物质和细胞,将有助于解决这一重建障碍。然而,CaP 的结构特征(即结构和组成)仍需要定制,并且加工干细胞和合成活性物质(例如重组人骨形态发生蛋白 2)的使用极大地限制了这些方法的临床应用。专注于可直接转化为临床环境的解决方案,双相磷酸钙 (BCP) 和碳酸化羟基磷灰石 (CHA) 3D 打印具有三重周期性最小结构 (TPMS) 的圆盘,分别在有无添加全骨髓 (TBM) 的情况下植入颅顶临界尺寸缺损(大鼠模型)中。评估缺损内的骨再生情况,并将结果与基于 TBM 浸泡的 BCP 颗粒的标准护理程序(阳性对照)进行比较。7 周后,CHA 磁盘+TBM 组的新骨形成明显大于阳性对照组(分别为 3.33mm 和 2.15mm,P=0.04)。这些令人鼓舞的结果表明,CHA 和 TPMS 结构都有可能有利于 CSD 的修复,并且这种一步法值得进一步的临床研究。